5-177282522-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_022455.5(NSD1):c.5950C>T(p.Arg1984*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_022455.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 17565729, 26633545, 30921091, 15942875, 25852445, 15742365, 28475857) -
This sequence change creates a premature translational stop signal (p.Arg1984*) in the NSD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12464997, 14571271, 15942875, 16247291). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Sotos syndrome (PMID: 15742365, 15942875, 25852445). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 209175). For these reasons, this variant has been classified as Pathogenic. -
Sotos syndrome Pathogenic:2
This variant has been previously reported as disease-causing and was found once in our laboratory de novo in an 18-year-old male with intellectual disability, spasticity, seizures, dysmorphic features, syndactyly, onset of an inflammatory syndrome at 17 years -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at